| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |